Loading data for EMBC — first visit, this takes a few seconds.
Embecta Corp. (EMBC)
NasdaqGS: EMBC
· Real-Time Price · USD
4.99
-0.24 (-4.59%)
At close: Aug 26, 2026, 3:59 PM
The price, the headline numbers and the latest news, in one place.
Embecta Corp. (EMBC) Stock Price, Analysis & Data
-4.59% (1D)
| Bid | 3.68 |
| Market Cap | 278.2M |
| Revenue (ttm) | 1.02B |
| Net Income (ttm) | 87.5M |
| 0.79 | |
| 1.47 | |
| 3.34 | |
| 2.79 | |
| P/B (ttm) | -0.45 |
| P/S (ttm) | 0.27 |
| Earnings Date | Nov 25, 2026 |
| Ask | 6.37 |
| Volume | 991,793 |
| Avg. Volume (20D) | 1,899,367 |
| Open | 5.21 |
| Previous Close | 5.23 |
| Day's Range | 4.95 - 5.27 |
| 52-Week Range | 2.77 - 15.55 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.04 (0.81%) |
| Ex-Dividend Date | Aug 27, 2026 |
About EMBC
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company's products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, In...
Industry Medical Instruments & Supplies
Sector Healthcare
IPO Date Mar 22, 2022
Employees 1,850
Stock Exchange NasdaqGS
Ticker Symbol EMBC
Website https://www.embecta.com
Financial Performance
In 2025, Embecta's revenue was 1.08B, a decrease of -3.8% compared to the previous year's 1.12B. Earnings were 95.4M, an increase of 21.84%.
Financial StatementsEarnings Surprise
Embecta has released their quarterly earnings on Aug 7, 2026:
- Revenue of $271.7M misses estimates by $0, with -8.05% YoY decline.
- EPS of 0.56 exceeds estimates by 0.29, with -50.00% YoY decline.
Embecta Corp. is scheduled to release its earnings on Nov 25, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2